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Abstract
Background Malnutrition is associated with poor outcomes in surgical patients and corrective enteral feeding may not be 
possible. This is a particular problem in the acute setting where malnutrition is prevalent. The aim of this systematic review 
was to evaluate the use of parenteral nutrition (PN) in critically ill surgical patients.
Methods This review was registered with PROSPERO (CRD42017079567). Searches of the CENTRAL, EMBASE, and 
MEDLINE databases were performed using a predeined strategy. Randomised trials published in English since 1995, report-
ing a comparison of PN vs any comparator in a critically ill surgical population were included. The primary outcome was 
mortality. Risk of bias was assessed using the Cochrane risk of bias tool and the Grading of Recommendations Assessment, 
Development and Evaluation assessment. Meta-analysis was performed using a random efects model to assess variation in 
mortality and length of stay.
Results Fourteen RCTs were identiied; standard PN was compared vs other forms of PN in ten studies, to PN with variable 
dose amino acids in one, and to enteral nutrition (EN) in three. In trials comparing glutamine-supplemented PN (PN-GLN) 
to PN, a non-signiicant reduction in mortality was noted (risk diference − 0.08. 95% CI − 0.17, 0.01, p = 0.08). A trend for 
a reduction in length of stay was seen in PN-GLN to PN comparator (mean reduction − 2.4, 95% CI − 7.19 to 2.32 days, I2 
= 92%). Impact on other outcome measures varied in direction of efect.
Conclusions PN may ofer beneit in critically ill surgical patients. The size and quality of studies lead to uncertainty around 
the estimates of clinical efect, meaning a robust trial is required.
Keywords Nutritional support · Surgery · Critical illness · Gastrointestinal failure · Review
Introduction
Malnutrition is a well-documented challenge in surgery 
as it is associated with delayed healing, higher rates of 
complications and prolonged length of hospital stay [1–3]. 
A high proportion of patients admitted under the care of 
gastrointestinal surgeons are at risk of malnutrition, and 
reaching appropriate caloric intake in the postoperative 
period is problematic [4]. Most general surgery patients 
have an element of gastrointestinal failure either due 
to their primary pathology or due to surgical interven-
tion, and cannot absorb nutrition as needed [5, 6]. These 
patients may require support by other methods, which may 
include intravenous luids or the use of parenteral nutrition 
(PN). Problems related to malnutrition and intestinal fail-
ure may be compounded further if the patient is admitted 
to hospital with an acute surgical pathology: the patient 
may have endured acute gastrointestinal dysfunction or 
K. Ledgard and B. Mann are co-irst authors and they contributed 
equally to the work.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s1015 1-018-1875-1) contains 
supplementary material, which is available to authorized users.
  M. J. Lee 
 m.j.lee@sheield.ac.uk
1 University of Sheield Medical School, Sheield, UK
2 School of Health and Related Research, University 
of Sheield, Sheield, UK
3 Department of General Surgery, Northern General Hospital, 
First Floor, Old Nurses Home, S5 7AU Sheield, UK
756 Techniques in Coloproctology (2018) 22:755–766
1 3
failure for a period of time prior to admission and be in 
nutritional deicit. Current guidance in advocates that 
PN is not typically be started until 5–7 days post-surgery 
unless the patient has high nutritional risk or is in a hyper-
metabolic state [7–9]. The same guidance acknowledges 
that it is based upon low-to-moderate quality evidence.
There is a signiicant body of literature on the use of PN 
in the critical care setting [10]. Unfortunately, this cannot 
be easily translated to the general surgical population as it 
includes a large number of patients with non-surgical diag-
noses. This population is unlikely to have the same degree of 
gastrointestinal dysfunction (mechanical or otherwise) as the 
gastrointestinal surgical population. PN has been established 
in elective perioperative nutrition for 25 years [11]; however, 
recent work evaluating its use in acute surgical admissions 
has shown variation in practice [12]. One reason for this may 
be an incomplete evidence base.
The aim of this study was to conduct a systematic review 
and meta-analysis to evaluate the efect of PN in critically 
ill gastrointestinal surgery patients with respect to mortality, 
length of stay and other complications of care.
Materials and methods
Protocol and registration
This review was conducted in accordance with the 
COCHRANE handbook [13], and reported with reference 
to the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines [14]. It was 
prospectively registered on the PROSPERO database 
(CRD42017079567).
Eligibility criteria
Eligible studies were randomised controlled trials (RCTs) 
published in English, after 1995. For inclusion, the studies 
had to report outcomes of critically ill surgical patients. The 
patient group was deined as those requiring intensive care 
admission following elective or emergency abdominal gas-
trointestinal surgery (e.g. laparotomy, colorectal resection). 
Studies were eligible where they compared any form of PN 
to another form of PN, PN with enteral nutrition (EN), EN 
alone, placebo, or no nutrition intervention.
Excluded studies were those in which patients had elec-
tive preoperative feeding, paediatric cases, conditions 
treated by surgeons which do not require surgical inter-
ventions (e.g. pancreatitis) or trials involving packaged 
interventions. Studies reporting trauma populations were 
excluded.
Outcomes
The primary outcome was mortality. Secondary outcomes 
were hospital length of stay (LOS), hospital acquired 
infections (HAIs), nitrogen balance and weight change.
Information sources
Searches were performed of the Cochrane Central Register 
of Controlled Trials (CENTRAL) in the Cochrane Library 
(all time), MEDLINE (Ovid SP) from 1946 to Septem-
ber 2017 and Embase (Ovid SP) from 1974 to September 
2017, which used no limits and combined Boolean opera-
tors, free text terms and thesaurus terms, no language or 
date limitation was applied. The search strategies used are 
given in Appendix 1 in Supplementary material. Addi-
tional citations were identiied through expert recommen-
dations and hand-searching of citations.
Study selection
Search results were imported into a citation management 
program (Covidence.org) and duplicates removed. Two 
investigators independently screened articles for eligibil-
ity against predeined exclusion criteria at the title/abstract 
and full-text stage; conlicts were resolved by a discussion 
with a third investigator.
Data extraction
Data were extracted into predeined tables by two review-
ers and compared, with disagreements resolved as above. 
The following items were recorded: author, year, study 
design, basic population demographics, intervention and 
control arms, primary outcomes, and secondary outcomes 
including LOS, weight change, mortality at 6 months, 
mortality within the hospital admission, HAIs, complica-
tions and nitrogen balance. Nitrogen balance is a method 
used to estimate protein balance. Critically ill patients 
are typically in a catabolic state and will have a negative 
nitrogen balance (i.e. protein intake is not adequate). A 
positive or neutral balance shows that needs are being met 
or exceeded [15].
Risk of bias of individual studies
The Cochrane Risk of Bias tool was used independently by 
two authors to assess bias of relevant studies [13].
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Summary measures
The summary methods for results obtained varied, but 
included population means with standard errors, difer-
ences, ratios, binary results with conidence ratios and 
tests of signiicance.
Synthesis of results
Pre-planned meta-analysis using a random efects model 
was used to assess risk diference for mortality, and mean 
diference for length of stay with Revman v5.3 software 
(Cochrane Collaboration, Copenhagen).
Risk of bias across studies
Using the GRADE PRO tool, bias was assessed across the 
studies for the primary outcome of death, within all com-
parators [16].
Results
Study selection
The search identiied 2638 references (Fig. 1). Following 
the removal of duplicates, 1636 papers, were screened for 
inclusion. Eighty-six papers were reviewed at full text, and 
14 of them were included in the review. Seventy-two were 
rejected at this stage for the following reasons: no PN com-
parator (n = 28), non-emergency population (n = 25), article 
in not in the English language (n = 8), no placebo comparator 
(n = 2), ineligible comparator (n = 2), ineligible intervention 
(n = 2), ineligible patient population (n = 2), ineligible study 
design (n = 2), published before 1995 (n = 1).
Study characteristics
The included studies included ten trials comparing standard 
PN against a supplemented PN [1, 17–25]; three trials com-
paring PN against EN [26–28], one of which also compared 
PN to no nutrition intervention [26] and one trial comparing 
Fig. 1  PRISMA low diagram
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PN to PN with variable doses of amino acids based upon 
blood tests [29] (Table 1/Fig. 2).
Four studies reported mortality [18, 19, 22, 25, 27], some 
within hospital others at 6-month follow-up, those with the 
same intervention and control arms have been meta-analysed 
below; seven trials reported new-onset or hospital-acquired 
infections [1, 18, 21, 22, 25, 27, 28]; seven trials reported 
length of stay [18, 19, 21, 22, 25, 27, 28], and four trials 
reported nitrogen balance [21, 24, 27, 29] (Table 2). A sum-
mary of all reported outcomes is presented in Table S1.
Risk of bias within studies
Two studies had high risk and six an unclear risk of bias 
from the sequence generation method. Three studies had 
a high and seven an unclear risk of bias from the alloca-
tion concealment method. Five trials had high-risk meth-
ods of blinding patients and clinicians, half had a low 
risk. Six studies had high-risk blinding of assessments 
and two studies were unclear. No study had a high risk 
Table 1  Summary of study characteristics
PN parenteral nutrition, EN enteral nutrition, Al alanine, GLN-PN glutamine-supplemented PN
Author (year) Population Total 
popula-
tion (N)
Intervention Control
Ahrens (2005) [1] Consecutive patients requiring 
parenteral nutrition in a level I 
trauma centre
40 Low-calorie PN Standard-calorie PN
Antebi (2003) [17] ICU patients undergoing major 
abdominal surgery
20 SMOF PN regimen LIPOVEN PN regimen
Berard (2002) [29] Surgical intensive care patients 
(SICU), requiring PN for 10 
days
13 5 day PN as standard, 5 days PN 
individualised
10-day PN
Chen (2017) [28] Conirmed gastric outlet obstruc-
tion patients
68 PN 7 days preoperatively Increasing EN 14 days before 
surgery
Estivariz (2008) [18] Pancreatitic and non-pancreatitic 
surgical intensive care patients 
requiring PN
59 GLN-PN GLN-free PN
Goeters (2002) [19] Post-operative intensive care unit 163 Al-Gln-supplemented PN GLN-free PN
Hu (2003) [26] Post-operative patients with 
impaired liver function (Child 
B or C)
35 PN or EN (via jejunostomy) No nutritional intervention
Hulsewe (2004) [20] Nutritionally depleted gastroin-
testinal surgery patients
24 Glycyl-glutamine supplemented 
PN
Isonitrogenous control solution PN
Jiang (1999) [21] Major gastrointestinal surgery 
patients requiring PN for 6 days
120 Al-Gln supplemented PN GLN-free PN
Luo (2008) [23] Surgical intensive care patients GLN-PN GLN-free PN
Malhotra (2004) [27] Emergency surgery for peritonitis 
following gut perforation
169 PN EN (NG feed)
Powell-Tuck (1999) [22] Patients requiring PN, surgical 
subgroup reported
168 GLN-PN PN
Wang (2003) [24] Major abdominal Surgery includ-
ing trauma
40 PN with BCAA PN with AA
Ziegler (2016) [18] Surgical intensive care patients 
requiring PN
150 GLN-PN Standard PN
Fig. 2  Summary of comparisons identiied. EN enteral nutrition, PN 
parenteral nutrition, BCAA branched chain amino acid, GLN-PN glu-
tamine supplimented parenteral nutrition
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of incomplete data and two trials were unclear. One trial 
had a high risk of selective reporting. Five studies had a 
high risk of other bias and five an unclear risk. Trials with 
control variables of EN or control (standard nutritional 
care) are open studies [26, 28]. Many of the trials had no 
statement of conflict of interest or funding sources while 
many others were funded by medical intervention manu-
facturers (Figs. 3, 4).
Synthesis of results
Mortality
In the comparison of PN-GLN to PN (4 studies, 413 
patients, Fig. 5), GLN-supplemented PN reduced risk of 
mortality by 8% (risk difference (RD) − 0.08, 95% CI 
− 0.17 to 0.01, p = 0.08), but this was not statistically 
significant. Statistical heterogeneity was low (I2 = 22%). 
The one trial comparing PN to EN did not observe a sta-
tistically significant reduction in death (RD − 0.05, 95% 
CI− 0.17 to 0.06, p = 0.37) [27].
Length of hospital stay
In the comparison of PN to EN, Malhotra showed no sig-
niicant reduction in LOS (mean diference − 0.11 days, 95% 
CI − 1.17 to 1.39, p = 0.085) [27]. Chen provided no con-
idence intervals; however, found a signiicant reduction in 
LOS for the PN group [28]. Meta-analysis comparing the 
efect of PN-GLN to PN in length of hospital stay (5 studies, 
474 patients, Fig. 6) found a trend towards reduced LOS in 
the glutamine-supplemented group (mean diference − 2.4, 
95%CI − 7.19 to 2.32 days). This was associated with high 
heterogeneity (I2 = 92).
Hospital-acquired infections
Seven studies reported HAI as an outcome. One study com-
paring low-calorie PN to high-calorie PN, found no signii-
cant reduction in HAI [1]. Two studies compared PN to EN 
(n = 232). Chen found a signiicant increase in HAI with PN, 
but data are incomplete, preventing further interpretation 
[28]. Malhotra found a non-signiicant reduction in HAI with 
the use of PN (relative risk = 0.66, 95% CI 0.407–1.091, 
p = 0.103) [27].
Table 2  Study comparators and 
outcomes
Tick shows that outcome was assessed for. HAI hospital-acquired infections, PN parenteral nutrition, EN 
enteral nutrition, BCAA branched-chain amino acids
In-hospital 
mortality
Length of 
stay
HAI Weight 
change
Mechanistic data, 
e.g. nitrogen balance
PN vs EN
 Malhotra [27] ᪦ ᪦ ᪦ ᪦ ᪦
 Chen [28] – ᪦ ᪦ ᪦ –
 Hu [26] – – – ᪦ ᪦
PN-GLN vs PN
 Estivariz [18] ᪦ ᪦ ᪦ – –
 Goeters [19] ᪦ ᪦ – – –
 Jiang [21] – ᪦ ᪦ – ᪦
 Powell-tuck [22] ᪦ ᪦ ᪦ – ᪦
 Ziegler [25] ᪦ ᪦ ᪦ – ᪦
 Hulsewe [20] – – – ᪦ ᪦
 Luo [23] – – – ᪦ ᪦
PN vs standard care
 Berard [29] – – – – ᪦
 Hu [26] – – – – ᪦
BCAA-PN vs PN-AA
 Wang [24] – – – – ᪦
SMOF-PN vs Lipoven
 Antebi [17] – – – – ᪦
Low calories PN vs standard calories PN
 Ahrens [1] – – ᪦ – –
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Fig. 3  Risk of bias summary
Fig. 4  Risk of bias graph
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Nitrogen balance
Five studies reported nitrogen balance, two of which compared 
PN to no-nutritional intervention (n = 83). Berard reported 
no signiicance, with no conidence intervals given [29]; Hu 
reported a signiicant improvement but with no conidence 
intervals [26]. Two studies compared PN to EN (n = 269), 
Malhotra found a signiicant beneit with PN (88% popula-
tion diference, p < 0.05) [27]; Hu found a signiicant beneit 
with EN [26], but neither gave conidence intervals. One study 
comparing PN with branched-chain amino acids (BCAA) and 
PN with amino acids (n = 40) found patients achieved positive 
nitrogen balance signiicantly quicker in the BCAA-supple-
mented group, conidence intervals not given (p < 0.05) [24].
Weight change
Four studies reported on weight change. Three studies com-
pared PN to EN (n = 337): Chen made no statistical com-
parison between the interventions [28]; Hulsewe reported no 
signiicant result and gives no data [20]; Hu reported no sig-
niicant diference between groups (mean diference − 0.3 kg) 
[26]; Malhotra found a signiicant reduction in weight loss 
with PN (mean diference = 2 kg, 95% CI − 1.54 to 2.46, 
p < 0.0001) [27]. One study comparing PN to no-nutrition 
intervention (n = 70) reported a signiicant diference without 
conidence intervals (PN mean weight loss − 2.4 ± 1.1 kg, con-
trol − 3.3 ± 1.7, p < 0.05.) [26]. Malhotra reported a greater 
weight loss in the intervention group than control (p < 0.05) 
[27]; however, this study included patients with faecal perito-
nitis who may have been more critically ill than those in any 
other study included.
Risk of bias across studies
For the outcome of death, GRADE assessment found the risk of 
bias across studies comparing PN-GLN to PN to be high. This 
was due to a lack of allocation concealment information, and 
imprecision in results. In trials comparing PN to EN, there is 
a high risk of bias as due to the methodology of being an open 
trial, they cannot be blinded. A number of other concerns were 
noted including small population sizes, and the roles of funding 
sources [30]. The GRADE assessment is presented in Table 3.
Discussion
This review suggests there may be beneit from the use of 
PN in the critically ill surgical patient with gastrointes-
tinal failure, in terms of reduced LOS. The efect of PN 
Fig. 5  Meta-analysis of in-hospital mortality, PN-GLN (glutamine-supplemented parenteral nutrition), PN (parenteral nutrition), CI (conidence 
intervals), and SD (standard deviation)
Fig. 6  Meta-analysis of length of stay, PN-GLN (glutamine-supplemented parenteral nutrition), PN (parenteral nutrition), CI (conidence inter-
vals), SD (standard deviation)
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Table 3  GRADE PRO—risk of bias across studies
CI conidence interval, RR risk ratio, PN parenteral nutrition, PN-GLN glutamine-supplemented parenteral nutrition, EN enteral nutrition
a Allocation concealment and random sequence generation was a high risk in two studies
b Estivariz has signiicantly wider conidence intervals than other studies
c A single-blinded trial, with unclear allocation concealment
d Wide 95% conidence intervals (− 5.78 to 13.68)
Certainty assessment No. of patients
Number of events/total participants 
(percentage)
Efect Certainty Importance
No. of stud-
ies
Study 
design
Risk of bias Inconsist-
ency
Indirectness Imprecision Other 
considera-
tions
PN-GLN Standard 
PN
Relative 
(95% CI)
Absolute 
(95% CI)
PN-GLN compared to standard PN for critically ill surgical patients and associated mortality rates
 Death—PN-GLN vs standard PN (follow-up: median 28)
  4 Randomised 
trials
Serious a Not serious Not serious Serious b None 33/239 (13.8%) 48/233 
(20.6%)
RR 0.70 
(0.47 to 
1.04)
62 fewer 
per 1000 
(from 8 
more to 
109 fewer)
⨁⨁◯◯
LOW
CRITICAL
PN compared to EN for critically ill surgical population and associated mortality rates
 Death
  1 Randomised 
trials
Serious c Not serious Not serious Serious d None 12/83 
(14.5%)
16/81 
(19.8%)
RR 0.660 
(0.700 to 
1.091)
67 fewer 
per 1000 
(from 18 
more to 
59 fewer)
⨁⨁◯◯
LOW
CRITICAL
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on HAIs is not clear, and there is no clear mortality ben-
eit. The literature is based upon small trials with a high 
level of heterogeneity and bias and should be interpreted 
accordingly. There is, however, signal that some forms of 
PN may ofer beneits to the critically ill surgical patient.
The body of literature addressing nutritional support 
in acutely ill surgical patients is limited; it includes many 
heterogenous populations, small trials, with heterogeneity 
of interventions and outcomes. This makes robust assess-
ment challenging. Critically, there are few, if any, trials of 
PN vs no nutritional support or placebo control, making 
it diicult to estimate the absolute beneit of nutritional 
intervention in this setting. Trials of PN in the intensive 
care population have failed to show consistent signiicant 
beneit [31], although these trials included patients with 
functioning gastrointestinal tracts/non-surgical patients 
where enteral nutrition might be preferable. A recent 
pilot trial signalled that the surgical subgroup of patients 
may derive greater beneit from PN-based interventions 
than medical comparators [32]. The evidence base is also 
limited as recruitment to trials in the emergency surgical 
setting can be challenging—further thought is needed on 
how best to tackle this problem, otherwise we may not be 
able to tease out the true efect of nutritional support in 
the critically ill surgical patient. This study focussed on 
the role of PN in patients following surgery, and not in 
the treatment of patients with complications such as anas-
tomotic leak or enterocutaneous istula, where its role is 
more deined [6].
The efect of interventions on mortality suggests a mod-
est beneit of PN, particularly glutamine-supplemented 
PN. This is mechanistically plausible as PN may arrest 
the catabolic phase and provide calories avoiding cellular 
exhaustion [33]. Our inding of a potentially reduced LOS 
is at odds with some reviews [34], although studies of 
patients in intensive care have shown beneit in PN reduc-
ing LOS [35]. Preoperative PN has a known association 
with shorter postoperative LOS in elective patients [36]. 
Additional beneits for PN-GLN may come from the anti-
oxidant properties of glutamine as a substrate for synthesis 
of glutathione [37, 38], and its reported role in preserva-
tion of the intestinal epithelial barrier through enterocyte 
nutrition [39]. Additionally, glutamine is also a substrate 
for gluconeogenesis in the liver and may support mobi-
lisation of energy reserves [40]. Reviews of recent trials 
have challenged the beneit of glutamine supplementation 
[41], and it has fallen out of favour to some extent [42]. 
In variance with the intensive care literature, the consist-
ent beneit of glutamine supplementation of PN is seen in 
other acute surgical conditions such as acute pancreatitis 
(which was not included in this study) [43]. This may sug-
gest that glutamine ofers beneits to patients with gastro-
intestinal pathology, perhaps from the proposed beneits 
for enterocytes. Alternatively, there may be fundamental 
diferences in the design, conduct, and outcome measures 
used in the diferent trials which guide us to incorrect 
conclusions.
Qualitative assessment of the association between nutri-
tional intervention and HAIs suggests a possibility of ben-
eit. Unfortunately, as varying outcomes and deinitions were 
used across studies, we were unable to pool these data for 
meta-analysis. A reduction in HAIs is a plausible efect as 
there is evidence linking infections with acute malnutrition 
due to the inadequate response of the immune system [44]. 
This correlates with other reviews and studies reviewing 
malnutrition in intensive care populations, in elderly popu-
lations and in cancer patients where malnutrition is common 
[45–48].
Current guidelines advocate the use of EN where possi-
ble in surgical patients, where they are able to tolerate feed 
and do not have contraindications such as perforation, istula 
or ischaemia [6, 9]. They advise the use of PN in patients 
who have been without enteral nutrition for 5–7 days, with 
hypermetabolic state or signiicant malnutrition, and also 
where there is likely to be a signiicant duration of parenteral 
therapy (> 7 days) [7, 9]. There is moderate-to-low evidence 
supporting the use of supplements such as ish oils or argi-
nine for their immunomodulation properties in postoperative 
patients [9]. As previously, it is important to note that most 
of this evidence comes from either medical intensive care 
or patients undergoing elective surgery, so generalisability 
may be limited.
Special consideration must be given to the efect of hyper-
glycaemia in critical illness. This may be observed during 
therapy with PN, and the associated hyperglycaemia has 
been shown to cause signiicantly higher rates of morbidity 
in the intensive care population [49]. The study reporting 
this inding was published in 2006. All but one study in 
this review were published before this date, and glycaemic 
management, therefore, may not have been optimal. This is 
one change in practice that might alter the indings if some 
of these studies were repeated today. Current guidance advo-
cates close monitoring and intervention in hyperglycaemia 
[9].
There are several limitations to this systematic review, 
primarily the limited body of studies relevant to our popu-
lation; however, a review is only as good as the litera-
ture upon which it is based. There is a high level of bias 
for some of the included trials, with concerns related to 
funding. Bias, reliability and the small size of studies may 
afect validity of many of the trials available [50]. There 
are also many diferent outcome measures across the trials; 
these often are non-comparable due to diferent interven-
tions or comparators, e.g. HAIs, making pooling diicult. 
There may also be diferences in the preparation of PN 
used, and the calculations used to estimate caloric need 
764 Techniques in Coloproctology (2018) 22:755–766
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[51], leading to variation in the interventions and sub-
sequent outcomes [52]. However, the review is a robust 
systematic review that was conducted methodically with 
reference to the Cochrane handbook, and used best prac-
tice bias assessment with Cochrane Risk of Bias tool and 
GRADE PRO. Whilst it does not tell us clearly that PN is 
of signiicant value vs no nutrition, it does highlight that 
further research is required.
The outcomes reported in this review—mortality, hospi-
tal-acquired infections and length of stay—are important for 
patients and clinicians alike. PN is a mechanistically plausi-
ble intervention to improve these outcomes in the critically 
ill surgical patient. There is uncertainty about the true efect 
of PN in this population, meaning there is a clear need for 
randomised controlled trials. Key questions that research 
should answer include (i) whether PN ofers beneit to the 
patient group compared to no nutrition support, (ii) whether 
early PN (e.g. < 24 h from admission) is better than delayed 
PN (e.g. 5 days or more after admission), (iii) whether glu-
tamine supplementation ofers clear beneit to this patient 
group, and (iv) what are the characteristics of patients who 
might beneit from these interventions. These studies should 
use patient and clinician important outcomes (e.g. quality of 
life, complications) rather than mechanistic outcomes (e.g. 
nitrogen balance) to determine if they are of tangible beneit.
Conclusions
In critically ill surgical patients, the use of PN may ofer 
beneit in key outcomes. The size and quality of the stud-
ies lead to considerable uncertainty around the estimates 
of clinical efect, meaning a large-scale randomised con-
trolled trial is required.
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